Health Equity: A Call to Action for Innovators, Clinical Leaders, and Policymakers
- PMID: 39129996
- PMCID: PMC11312352
- DOI: 10.1016/j.jacadv.2024.100982
Health Equity: A Call to Action for Innovators, Clinical Leaders, and Policymakers
Keywords: health equity; health policy; technological innovation.
Conflict of interest statement
Dr Johnson has received research support from the 10.13039/100000050National Heart, Lung, and Blood Institute (K23HL165110); and has received honoraria from 10.13039/100004339Sanofi and 10.13039/100006520Edwards Lifesciences. Dr Aubrey Grant is a co-founder and chief equity officer for Equity Commons. Dr Maddox receives research support from the 10.13039/100000050National Heart, Lung, and Blood Institute (R01HL143421 and R01HL164561), the 10.13039/100000056National Institute of Nursing Research (U01NR020555), the 10.13039/100000049National Institute on Aging (R01AG060935, R01AG063759, and R21AG065526), and the 10.13039/100006108National Center for Advancing Translational Sciences (UL1TR002345); serves as an associate editor for the Journal of the American Medical Association (JAMA); previously served on the Health Policy Advisory Council for the Centene Corporation (St. Louis, MO); has received research funding from 10.13039/100014940Humana. Dr Ogunniyi has received institutional research grant support from AstraZeneca, 10.13039/100001003Boehringer Ingelheim, Cardurion Pharmaceuticals, and 10.13039/100004319Pfizer; and serves on the V-INCLUSION trial steering committee. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures

References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous